[an error occurred while processing this directive]
临床研究

NLRP3/IL-1β 信号通路活化与维持性血液透析患者血高密度脂蛋白胆固醇降低相关

  • 邱杰山
展开
  • 1仙居县人民医院(浙江省人民医院浙东南院区)肾脏内科何强名医工作室
    2浙江省人民医院肾脏内科

收稿日期: 2021-09-16

  修回日期: 2022-01-19

  网络出版日期: 2022-04-07

基金资助

仙居县人民医院青年创新人才支持计划(21yja02);台州市科技局科研项目(1702KY69);武威市科技计划项目(ww180262)

Activation of NLRP3/IL-1β signaling pathway is associated with reduction of HDL-C in patients with maintenance hemodialysis

  • QIU Jie-Shan
Expand
  • 1Department of Nephrology, Xianju People’s Hospital, East and South district of Zhejiang Provincial People's Hospital, Xianju 317300, China;  2Zhejiang Provincial People's Hospital, Hangzhou 317000, China

Received date: 2021-09-16

  Revised date: 2022-01-19

  Online published: 2022-04-07

摘要

【摘要】目的探讨维持性血液透析(maintenance hemodialysis,MHD)患者Nod 样受体蛋白3/白细胞介素-1β(Nod-like receptor protein 3/interleukin 1β,NLRP3/IL-1β)信号通路活化与高密度脂蛋白胆固醇(high density lipoprotein cholesterol,HDL-C)水平及动脉粥样硬化(atherosclerosis, AS)发生的关系。方法行MHD 治疗的患者83 例为研究组,20 例健康人为对照组,检测生化指标、HDL-C、血白细胞介素(IL)-1β、IL-18 及外周血单核细胞NLRP3mRNA;测定颈动脉内膜中层厚度(intimamedia thickness,IMT)。比较2 组间上述指标的差异;分析HDL-C及颈动脉IMT与NLRP3mRNA、IL-1β及IL-18的相关性;明确影响MHD患者HDL-C水平及颈动脉IMT的危险因素。结果研究组MHD患者HDL-C低于对照组(t=-7.048, P<0.001),颈动脉IMT值大于对照组(t=2.634, P<0.001);血HDL-C与NLRP3mRNA ( r=-0.682, P<0.001)、IL-1β(r=-0.537, P<0.001)及IL-18(r=-0.426, P<0.001)呈负相关;颈动脉IMT与NLRP3mRNA (r= 0.521,P<0.001)、IL-1β(r=0.569,P<0.001)及IL-18(r=0.674,P<0.001)成正相关;NLRP3mRNA 活化是HDL-C 降低的危险因素(B=-0.390,p<0.001),而NLRP3mRNA、IL-18 活化(B=0.069、0.002,均P<0.001)及HDL- C 降低(B=- 0.106,P<0.001)是MHD 患者颈动脉IMT 增厚的危险因素。结论NLRP3/IL-1β 信号通路参与了MHD患者血HDL-C 水平降低及颈动脉IMT 增厚。

本文引用格式

邱杰山 . NLRP3/IL-1β 信号通路活化与维持性血液透析患者血高密度脂蛋白胆固醇降低相关[J]. 中国血液净化, 2022 , 21(04) : 235 -239 . DOI: 10.3969/j.issn.1671-4091.2022.04.003

Abstract

【Abstract】Objective To investigate the relationship between of Nod-like receptor protein 3/interleukin-1β (NLRP3/IL-1β) signaling pathway activation and blood high-density lipoprotein cholesterol (HDL-C) level and atherosclerosis (AS) in patients with maintenance hemodialysis (MHD). Methods A total of 83 patients who underwent MHD were collected as the study group, and 20 healthy individuals as the control group. Their biochemical indexes, HDL-C, serum IL-1β, interleukin-18 (IL-18) and NLRP3 mRNA were assayed, and the carotid intima-media thickness (IMT) was measured. The differences of these results were compared
between the two groups. The correlations between HDL-C and NLRP3 mRNA, carotid artery IMT and NLRP3 mRNA, and IL-1β and IL-18 were analyzed respectively. The risk factors affecting HDL-C level and carotid IMT in MHD patients were explored. Results HDL-C level was lower in MHD patients than in the control group (t=-7.048,P<0.001), while carotid IMT value was higher in MHD patients than in the control group (t=2.634,P<0.001). HDL- C was negatively correlated with NLRP3 mRNA (r=- 0.682, P<0.001), IL- 1β (r=-0.537, P<0.01) and IL-18 (r=-0.426, P<0.01). Carotid artery IMT was positively correlated with NLRP3 mRNA (r=0.521, P<0.001), IL-1β (r=0.569, P<0.001) and IL-18 (r=0.674, P<0.001). Hence, the activation of NLRP3 mRNA was the risk factor for low HDL-C level (B=-0.390, P<0.001), while the activation of NLRP3 mRNA (B=0.069, P<0.001) and IL-18 signals (B=0.002, P< 0.001) and the decrease of HDL-C (B=-0.106, P<0.001) were the risk factors for the increase of carotid IMT in MHD patients. Conclusion NLRP3/IL-1β signal pathway is involved in the decrease of blood HDL-C level and the thickening of carotid artery IMT in
MHD patients.

参考文献

[1]Bressendorff I,Hansen D,Schou M,et al.The Effect of Increasing Dialysate Magnesium on Serum Calcification Propensity in Subjects with End Stage Kidney Disease:A Randomized,Controlled Clinical Trial[J].Clin J Am Soc Nephrol, 2018, 13(9):1373-1380.
[2]Vavilis G,B?ck, Magnus, Occhino G,et al. Kidney Dysfunction and the Risk ofDeveloping Aortic Stenosis[J].Journal of the American College of Cardiology, 2019,73(3):305-314.
[3]Razzak MA,Fatimak K,Miah OF,et al.Risk of abdominal aorticcalcifications among end stage renal disease patients under maintenance hemodialysis[J]. Mymensingh Med J,2019,28(3):600-604.
[4]Ter Braake A D,Smit A E,Bos C,et al.Magnesium prevents vascular calcification in Klothodeficiency[J].Kidney Int, 2020, 97(3):487-501.
[5]Hénaut L,Candellier A,Boudot C,et al.New Insights into the Roles of Monocytes/Macrophages in Cardiovascular Calcification Associated with Chronic Kidney Disease[J].Toxins (Basel),2019,11(9):529.
[6] Choi H,Dey AK,Priyamvara A,et al.Role of Periodontal Infection, Inflammation and Immunity in Atherosclerosis[J].Curr Probl Cardiol,2021,46(3):100638.
[7] Hang L,Peng Y,Xiang R,et al.Ox-LDL causes endothelial cell injury through ASK1/NLRP3-mediated inflammasome activation via endoplasmic reticulum stress[J].Des Devel Ther,2020,14:731-744.
[8] Wang R,Wu W,Li W,et al.Activation of NLRP3 Inflammasome Promotes Foam Cell Formation in Vascular Smooth Muscle Cells and Atherogenesis Via HMGB1[J].J Am Heart Assoc,2018,2;7(19):e008596.
[9] Du X,Jiang S,Zeng X,et al.Air pollution is associated with the development of atherosclerosis via the cooperation of CD36 and NLRP3 inflammasome in ApoE -/- mice[J].Toxicol Lett,2018,15:290:123-132.
[10] Hung AM,Tsuchida Y,Nowak KL,et al.IL-1 Inhibition and Function of the HDL-Containing Fraction of Plasma in Patients with Stages 3 to 5 CKD[J].Clin J Am Soc Nephrol,2019,14(5):702-711.
[11] Ding X,Chen J,Wu C,et al.Nucleotide-Binding Oligomerization Domain-Like Receptor Protein 3 Deficiency in Vascular Smooth Muscle Cells Prevents Arteriovenous Fistula Failure Despite Chronic Kidney Disease[J].J Am Heart Assoc. 2019,8(1):e011211.
[12] Chen CL,Liu XC,Liu L,et al.U-Shaped Association of High-Density Lipoprotein Cholesterol with All-Cause and Cardiovascular Mortality in Hypertensive Population[J].Risk Manag Healthc Policy,2020,13:2013-2025.
[13] Paiva-Lopes MJ,Batuca JR,Gouveia S,et al.Antibodies towards high-density lipoprotein components in patients with psoriasis[J].Arch Dermatol Res,2020 312(2):93-102.
[14] Liu J,Guo Z,Zhang Y,et al.LCK inhibitor attenuates atherosclerosis in ApoE -/- mice via regulating T cell differentiation and reverse cholesterol transport[J].J Mol Cell Cardiol,2020,139:87-97.
[15] Sun Y,Long J,Chen W,et al.Alisol B 23-acetate, a new promoter for cholesterol efflux from dendritic cells, alleviates dyslipidemia and inflammation in advanced atherosclerotic mice[J].Int Immunopharmacol,2021,99:107956.
[16] Li Y,Jiang HT,Han LB,et al.MiR-195 regulates CD40 to maintain Th17/Treg balance in rats with non-alcoholic fatty liver disease[J].Biomed Pharmacother, 2020,124:109930.
[17] Wu BJ,Li Y,Ong KL,et al.The Cholesteryl Ester Transfer Protein Inhibitor, des-Fluoro-Anacetrapib, Prevents Vein Bypass-induced Neointimal Hyperplasia in New Zealand White Rabbits[J].Sci Rep,2019,9(1):16183.
[18] Akcan N,Obaid M,Salem J,et al.Evidence in obese children: contribution of tri-ponderal mass index or body mass index to dyslipidemia, obesity-inflammation, and insulin sensitivity[J].J Pediatr Endocrinol Metab,2020,25,33(2):223-231.
[19] Sharma M,Schlegel MP,Afonso MS,et al.Regulatory T Cells License Macrophage Pro-Resolving Functions During Atherosclerosis Regression[J].Circ Res,2020,127(3):335-353.
[20] Wu J,Guo N,Chen X,et al.Coexistence of micro-inflammatory and macrophage phenotype abnormalities in chronic kidney disease[J].Int J Clin Exp Pathol,2020, 13(2):317-323.
[21]Amdur RL,Feldman HI,Gupta J,et al.Inflammation and progression of CKD: The CRIC study[J].Clin J Am Soc Nephrol,2016,11(9):1546-1556.
[22] Alvarenga L,Salarolli R,Cardozo LFMF,et al.Impact of curcumin supplementation on expression of inflammatory transcription factors in hemodialysis patients:A pilot randomized,double-blind,controlled study[J].Clin Nutr,2020,39(12):3594-3600.
[23]Zhang J,Liu X,Wan C,et al.NLRP3 inflammasome mediates M1 macrophage polarization and IL-1β production in inflammatory root resorption[J].J Clin Periodontol,2020,47(4):451-460.
[24] Clement M,Chen X,Chenoweth HL,et al.MARK4(microtubule affinity-regulating kinase 4)-dependent inflammasome activation promotes atherosclerosis-brief report[J].Arterioscler Thromb Vasc Biol,2019,39(8):1645-1651.
[25] Aukrust P,Mollnes TE,Halvorsen B,et al.Cholesterol crystals use complement to increase NLRP3 signaling pathways in coronary and carotid atherosclerosis EBioMedicine,2020,60:102985.
文章导航

/

[an error occurred while processing this directive]